Lyra Therapeutics ($LYRA)

Stock Image

LYRA Overview

Lyra Therapeutics, a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.The company's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration.Its product candidates include LYR-210 and LYR-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018.Lyra Therapeutics, Inc. was founded in 2005 and is headquartered in Watertown, Massachusetts. (From: StockAnalysis.com)

MORE ABOUT Lyra Therapeutics

Stay up to date with the best of Bullish each week.


Stay up to date with the best of Bullish each week.